Equities

NU Skin Enterprises Inc

NU Skin Enterprises Inc

Actions
  • Price (EUR)6.85
  • Today's Change0.00 / 0.00%
  • Shares traded1.12k
  • 1 Year change-56.37%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments270280356
Total Receivables, Net815744
Total Inventory280346400
Prepaid expenses624255
Other current assets, total8.963518
Total current assets702760873
Property, plant & equipment, net523544575
Goodwill, net231206206
Intangibles, net1056777
Long term investments------
Note receivable - long term------
Other long term assets245155149
Total assets1,8061,8211,906
LIABILITIES
Accounts payable445450
Accrued expenses185231308
Notes payable/short-term debt000
Current portion long-term debt/capital leases2925108
Other current liabilities, total714964
Total current liabilities329359530
Total long term debt487390274
Total debt516415382
Deferred income tax------
Minority interest------
Other liabilities, total168175190
Total liabilities984924994
SHAREHOLDERS EQUITY
Common stock0.090.090.09
Additional paid-in capital622613602
Retained earnings (accumulated deficit)1,8701,9391,912
Treasury stock - common(1570)(1569)(1527)
Unrealized gain (loss)------
Other equity, total(100)(87)(74)
Total equity822897913
Total liabilities & shareholders' equity1,8061,8211,906
Total common shares outstanding505050
Treasury shares - common primary issue414141
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.